Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.68
- Piotroski Score 2.00
- Grade Buy
- Symbol (XERS)
- Company Xeris Biopharma Holdings, Inc.
- Price $2.91
- Changes Percentage (-0.51%)
- Change -$0.02
- Day Low $2.82
- Day High $2.93
- Year High $3.64
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $5.75
- High Stock Price Target $6.60
- Low Stock Price Target $3.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.47
- Trailing P/E Ratio -4.96
- Forward P/E Ratio -4.96
- P/E Growth -4.96
- Net Income $-62,255,000
Income Statement
Quarterly
Annual
Latest News of XERS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Mike Tyson vs. Jake Paul live updates: Boxers fight tonight after slap at weigh-in
Former heavyweight champion Mike Tyson, 58, will face social media star Jake Paul, 27, in a boxing match at AT&T Stadium in Texas. The event will be streamed on Netflix with six fights before the main...
By NBC News | 3 days ago -
Cavs beats Sixers 114-106 to become 6th NBA team to start a season 13-0
Donovan Mitchell's late-game performance led the Cleveland Cavaliers to a 114-106 victory over the Philadelphia 76ers, making them the sixth team in NBA history to start a season 13-0....
By AP NEWS | 5 days ago -
Joel Embiid's return gives Sixers hope again -- but they've heard this song before
The Philadelphia 76ers suffered another loss at home against the New York Knicks, dropping to 2-8. Joel Embiid returned to action but struggled, while Karl-Anthony Towns led the Knicks to victory....
By The New York Times | 5 days ago
